Welcome to our dedicated page for NVE /NEW/ SEC filings (Ticker: NVEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NVE /NEW/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NVE /NEW/'s regulatory disclosures and financial reporting.
NVE Corp President & CEO Daniel A. Baker reported option-related insider transactions in NVE Corp common stock. On July 27, 2026 he exercised 15,000 incentive stock options through cashless net option exercises, receiving common shares, and reported net sales of 20,000 shares at prices around $114–$118 between July 27 and 29, 2026. All incentive stock options on this form would expire three months after his retirement.
NVE Corp director Wei Xuan Kelly exercised non-qualified stock options covering 1,500 shares of common stock on 2026-07-27 through a cashless net option exercise. Options with exercise prices of $81.96 (1,000) and $61.72 (500) were converted, resulting in the acquisition of 538 common shares at $117.38 per share, which Kelly now holds directly.
NVE Corporation reported higher revenue and earnings for the quarter ended June 30, 2026, the first quarter of fiscal 2027. Total revenue was $11,034,057, up 81% from the prior-year quarter, driven by an 82% increase in product sales to $10,734,735 and higher contract R&D revenue. Gross profit was $8,968,012, an 81.3% margin.
Operating expenses rose to $1,702,176 as the company increased research and development and performance-based compensation. Net income was $6,394,191, or $1.32 per diluted share, up from $3,575,818, or $0.74, a year earlier. Cash from operating activities was $5,306,318, and cash and cash equivalents were $2,896,148. Total assets were $62,116,940, with marketable securities and money market funds representing approximately 69% of total assets.
The company paid a $1.00 cash dividend per share in the quarter and subsequently declared another $1.00 dividend payable August 31, 2026. Management reports effective disclosure controls, no material legal proceedings, and no material changes to previously disclosed risk factors.
NVE Corporation reported very strong results for the quarter ended June 30, 2026, the first quarter of fiscal 2027. Total revenue increased 81% to $11,034,057 from $6,104,644 in the prior-year quarter, driven by an 82% increase in product sales to $10,734,735 and a 53% increase in contract research and development revenue to $299,322.
Net income rose 79% to $6,394,191, or $1.32 per basic and diluted share, compared with $3,575,818, or $0.74 per share, a year earlier. Gross profit nearly doubled to $8,968,012 from $4,922,121, while operating expenses grew more modestly to $1,702,176. Income from operations was $7,265,836 and income before taxes was $7,715,756.
As of June 30, 2026, total assets were $62,116,940 and shareholders’ equity was $59,779,790, with total liabilities of $2,337,150. The Board approved a quarterly cash dividend of $1.00 per share, payable August 31, 2026 to shareholders of record on August 3, 2026.
NVE Corporation announced a planned leadership transition and board expansion. Daniel A. Baker will retire as President and Chief Executive Officer effective at the Annual Shareholders’ meeting on August 6, 2026, and, pending shareholder approval, remain on the Board as Chairman.
The Board appointed Peter G. Eames, currently Vice President of Advanced Technology, as the next President and Chief Executive Officer effective at that meeting and nominated him to the Board. The Board also nominated current Chairman Terrence W. Glarner to remain a director and first-time nominee Carolyn W. Valentine to join the Board. If shareholders approve all nominees, the Board will increase from five to seven directors.
The Compensation Committee set Dr. Eames’ annual base salary at $260,000 and approved a performance-based compensation plan equal to 0.3% of fiscal 2027 income from operations plus 2% of the increase in income from operations in fiscal 2027 compared to fiscal 2026. Non-employee directors, if elected or reelected, will receive an immediately vested nonqualified option to purchase 1,000 shares, except Dr. Baker, who will not receive this option if reelected.
NVE Corporation is asking shareholders to elect seven directors, approve executive compensation, and ratify Boulay PLLP as auditor at its August 6, 2026 annual meeting. The board will expand from five to seven members, with Peter G. Eames succeeding Daniel A. Baker as CEO while Baker becomes Chairman.
The proxy highlights strong profitability for fiscal 2026, including a 79% gross margin, 60% operating margin, 58% net margin, and higher operating cash flow. Executive pay is positioned as performance-based, tied mainly to income from operations and without pensions, golden parachutes, or executive perquisites. The filing also emphasizes board independence, AI and cybersecurity oversight, climate and human rights policies, and a clawback policy for incentive pay.
NVE Corp President and CEO Daniel A. Baker received a grant of 2,500 incentive stock options on May 8, 2026. These options allow him to acquire 2,500 shares of NVE Corp common stock at an exercise price of $90.21 per share between May 8, 2027 and May 8, 2036.
The options were granted as a compensation award at no cost per option on the grant date. Following this grant, Baker directly holds 17,500 incentive stock options linked to NVE Corp common stock.
NVE Corporation reports modestly higher results for the year ended March 31, 2026. Total revenue reached $26.3 million, up 1.8%, as product sales grew 2.4% and contract R&D declined 11% after certain contracts ended. Gross margin slipped to 79% of revenue from 84% due to a less profitable product mix and more distributor sales.
Operating expenses fell 15%, with research and development down 13% and selling, general, and administrative costs down 18% following resource shifts toward manufacturing and new products. Net income edged up 1% to $15.2 million, and the effective tax rate decreased to 15%, helped by $1.07 million of advanced manufacturing investment tax credits.
NVE ended the year with $1.7 million in cash and $41.8 million in marketable securities, representing about 69% of total assets, and paid $4.00 per share in cash dividends (about $19.3 million). The company continues to focus on spintronics-based sensors, couplers, power products, and MRAM, serving industrial, medical, and automation markets while highlighting risks from key customer dependence, supply-chain concentration, competition, and medical-device liability.
NVE Corporation reported modest full-year growth and stronger fourth-quarter results, and declared a cash dividend. Fourth-quarter fiscal 2026 revenue rose 5% to $7.65 million, driven by a 6% increase in product sales, while net income grew 27% to $4.93 million, or $1.02 per diluted share. For fiscal 2026, revenue increased 1.8% to $26.3 million and net income edged up 1% to $15.2 million, or $3.14 per diluted share. The Board approved a quarterly cash dividend of $1.00 per share, payable May 29, 2026 to shareholders of record on May 18, 2026. NVE highlighted continued strength in its spintronic sensors and couplers business and noted forward‑looking statement risks, including reliance on several large customers and economic conditions in its end markets.